{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:07:36Z","timestamp":1760148456393,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>There are currently two authorized vaccines against herpes zoster (HZ) that have been shown to be safe and effective in its prevention: Zostavax, a zoster vaccine live (ZVL), and Shingrix, a recombinant zoster Vaccine (RZV). Because ophthalmologists work with vision-threatening complications of zoster, such as herpes zoster ophthalmicus (HZO), they are in a good position to advocate for vaccination. Our aim was to determine the current knowledge among Spanish ophthalmologists about the effectiveness of the available vaccines against HZ. A Google Forms questionnaire was created and used as the survey platform for this study. It was an anonymous online survey of 16 questions, which was shared among Spanish ophthalmologists in-training and consultants from 27 April 2022 to 25 May 2022. The survey was completed by a total of 206 ophthalmologists of all subspecialties. We obtained responses from 17 of the 19 regions of Spain. Fifty-five percent of the respondents agreed that HZ is a frequent cause of vision loss. However, 27% of the professionals were unaware of the existence of vaccines against HZ and 71% of them did not know in which cases it could be indicated. Only nine ophthalmologists (4%) had ever suggested vaccination against HZ to their patients. Despite this, 93% considered it important to recommend vaccination against HZ if it proved to be safe and effective. Considering the sequelae, complications, and the existence of safe and effective vaccines against HZ, vaccination of the target population could be considered an important public health measure. We are convinced that it is time for ophthalmologists to take an active role in HZO prevention.<\/jats:p>","DOI":"10.3390\/vaccines11050952","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:04:48Z","timestamp":1683518688000},"page":"952","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster"],"prefix":"10.3390","volume":"11","author":[{"given":"Alberto","family":"S\u00e1nchez-Mellado","sequence":"first","affiliation":[{"name":"Hospital Universitario Virgen de las Nieves, Av. de las Fuerzas Armadas, 2, 18014 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Alcaraz-Clemente","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de las Nieves, Av. de las Fuerzas Armadas, 2, 18014 Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Rodr\u00edguez-Calvo-de-Mora","sequence":"additional","affiliation":[{"name":"Hospital Regional Universitario de M\u00e1laga, Plaza del Hospital Civil, S\/N, 29009 Malaga, Spain"},{"name":"Qvision, Department of Ophthalmology of VITHAS Almer\u00eda Hospital, 04120 Almer\u00eda, Spain"},{"name":"Ophthalmology Department, VITHAS M\u00e1laga, 29016 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-7717","authenticated-orcid":false,"given":"Jos\u00e9-Mar\u00eda","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Physics of Condensed Matter, Optics Area, University of Seville, 41012 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6929-3479","authenticated-orcid":false,"given":"Santiago","family":"Ortiz-Perez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de las Nieves, Av. de las Fuerzas Armadas, 2, 18014 Granada, Spain"},{"name":"Ophthalmology Department, VITHAS M\u00e1laga, 29016 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-2493","authenticated-orcid":false,"given":"Carlos","family":"Rocha-de-Lossada","sequence":"additional","affiliation":[{"name":"Hospital Regional Universitario de M\u00e1laga, Plaza del Hospital Civil, S\/N, 29009 Malaga, Spain"},{"name":"Qvision, Department of Ophthalmology of VITHAS Almer\u00eda Hospital, 04120 Almer\u00eda, Spain"},{"name":"Ophthalmology Department, VITHAS M\u00e1laga, 29016 Malaga, Spain"},{"name":"Surgery Department, Ophthalmology Area, University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ophtha.2018.08.029","article-title":"Herpes Zoster Eye Disease: New Ways to Combat an Old Foe?","volume":"125","author":"Jeng","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/ICU.0000000000000491","article-title":"Herpes Zoster Ophthalmicus: Acute Keratitis","volume":"29","author":"Li","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing Incidence of Herpes Zoster over a 60-Year Period from a Population-Based Study","volume":"63","author":"Kawai","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic Review of Incidence and Complications of Herpes Zoster: Towards a Global Perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pinchinat, S., Cebri\u00e1n-Cuenca, A.M., Bricout, H., and Johnson, R.W. (2013). Similar Herpes Zoster Incidence across Europe: Results from a Systematic Literature Review. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-170"},{"key":"ref_6","first-page":"25","article-title":"Vigilancia y Epidemiolog\u00eda Del Herpes Z\u00f3ster En Espa\u00f1a","volume":"95","author":"Carmona","year":"2021","journal-title":"Rev. Espa\u00f1ola Salud P\u00fablica"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marra, F., Chong, M., and Najafzadeh, M. (2016). Increasing Incidence Associated with Herpes Zoster Infection in British Columbia, Canada. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1898-z"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2019.10.001","article-title":"Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018","volume":"127","author":"Kong","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The Epidemiology of Herpes Zoster in the United States during the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns among Older Adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes Zoster Eye Complications: Rates and Trends","volume":"88","author":"Yawn","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of Herpes Zoster among Children: 2003\u20132014","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50\u201359 Years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ICU.0000000000000480","article-title":"Current Vaccines for the Prevention of Herpes Zoster","volume":"29","author":"Gibbons","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciab121","article-title":"Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study","volume":"73","author":"Sun","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","unstructured":"Ojeda Ruiz, E., Cordero, B.V., Sastre, M., Amillategui, R., Santos, D., Masa-Calles, J., L\u00f3pez-Perea, N., and Carmona Alf\u00e9rez, R. (, January August). Red Nacional de Vigilancia Epidemiol\u00f3gica Herpes Z\u00f3ster. Informe epidemiol\u00f3gico sobre la situaci\u00f3n de Herpes Z\u00f3ster en Espa\u00f1a, 1998-2018 Resultados de la Red Nacional de Vigilancia Epidemiol\u00f3gica Madrid. Madrid, Spain."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of Vaccination Coverage among Adult Populations-United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill. Summ."},{"key":"ref_18","unstructured":"Walensky, R.P., Anne Schuchat, D., Daniel Jernigan, P.B., Bunnell, R., Layden, J., Kent, C.K., Gottardy, A.J., Leahy, M.A., Martinroe, J.C., and Spriggs, S.R. (2023, April 09). Morbidity and Mortality Weekly Report Surveillance of Vaccination Coverage Among Adult Populations-United States, 2018 Surveillance Summaries Centers for Disease Control and Prevention MMWR Editorial and Production Staff (Serials) MMWR Editorial Board, Available online: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/ss\/ss7003a1.htm."},{"key":"ref_19","unstructured":"(2023, April 09). American Academy of Ophthalmology Recommendations for Herpes Zoster Vaccine for Patients 50 Years of Age and Older. Available online: https:\/\/www.aao.org\/education\/clinical-statement\/recommendations-herpes-zoster-vaccine-patients-50-."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/ICO.0000000000001771","article-title":"Herpes Zoster Vaccination: An Urgent Priority","volume":"37","author":"Galvis","year":"2018","journal-title":"Cornea"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/ICO.0000000000001582","article-title":"Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination","volume":"37","author":"Tsui","year":"2018","journal-title":"Cornea"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Schardt, C., Adams, M.B., Owens, T., Keitz, S., and Fontelo, P. (2007). Utilization of the PICO Framework to Improve Searching PubMed for Clinical Questions. BMC Med. Inform. Decis. Mak., 7.","DOI":"10.1186\/1472-6947-7-16"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.acra.2018.02.003","article-title":"Survey Research: A Primer for the Academic Radiologist","volume":"25","author":"Shankar","year":"2018","journal-title":"Acad. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bennett, C., Khangura, S., Brehaut, J.C., Graham, I.D., Moher, D., Potter, B.K., and Grimshaw, J. (2011). Reporting Guidelines for Survey Research: An Analysis of Published Guidance and Reporting Practices. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001069"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/intqhc\/mzg031","article-title":"Good Practice in the Conduct and Reporting of Survey Research","volume":"15","author":"Kelley","year":"2003","journal-title":"Int. J. Qual. Health Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5688\/aj720111","article-title":"Best Practices for Survey Research Reports: A Synopsis for Authors and Reviewers","volume":"72","author":"Draugalis","year":"2008","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_27","unstructured":"Peterson, R. (2014). Constructing Effective Questionnaires, SAGE Publications, Inc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1576-9887(11)70012-7","article-title":"Perception of Herpes Zoster in the General Population","volume":"12","author":"Sampedro","year":"2011","journal-title":"Vacunas"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amepre.2015.11.003","article-title":"Increasing Coverage of Appropriate Vaccinations: A Community Guide Systematic Economic Review","volume":"50","author":"Jacob","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S2468-2667(17)30234-7","article-title":"Evaluation of the Effect of the Herpes Zoster Vaccination Programme 3 Years after Its Introduction in England: A Population-Based Study","volume":"3","author":"Amirthalingam","year":"2018","journal-title":"Lancet Public Health"},{"key":"ref_31","unstructured":"Sanidad, Grupo de Trabajo (2023, April 09). Comisi\u00f3n de Salud P\u00fablica Del Consejo Interterritorial Del Sistema Nacional de Salud. Ministerio de Sanidad, Marzo 2021. Available online: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/HerpesZoster_RecomendacionesVacunacion.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Price, N.B., and Grose, C. (2021). Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination. Vaccines, 9.","DOI":"10.3390\/vaccines9010023"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.ophtha.2021.04.017","article-title":"Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States","volume":"128","author":"Lu","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251513552210845","DOI":"10.1177\/25151355221084535","article-title":"Global Herpes Zoster Incidence, Burden of Disease, and Vaccine Availability: A Narrative Review","volume":"10","author":"Pan","year":"2022","journal-title":"Ther. Adv. Vaccines Immunother."},{"key":"ref_35","unstructured":"Vallejo Torres, L., Linertov\u00e1, R., Sanrom\u00e1 Ramos, E., Ramos Garc\u00eda, V., Toledo Ch\u00e1varri, A., Herrera Ramos, E., P\u00e9rez Mart\u00edn, J.J., Limia S\u00e1nchez, A., Soler Soneira, M., and Castilla Catal\u00e1n, J. (2023, April 09). Coste-Efectividad de la Vacunaci\u00f3n Frente a Herpes Z\u00f3ster. Ministerio de Sanidad, Consumo y Bienestar Social. Servicio de Evaluaci\u00f3n del Servicio Canario de la Salud; 2018. Informes de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias. Available online: https:\/\/www3.gobiernodecanarias.org\/sanidad\/scs\/content\/05752564-e041-11e9-abf6-eb731501abed\/SESCS_2018_VacunasZoster.pdf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/11206721221093187","article-title":"Tips to Optimize Digital Education in Ophthalmology: Results from ESASO Survey","volume":"33","author":"Ferrara","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1038\/s41433-020-1061-3","article-title":"Reshaping Ophthalmology Training after COVID-19 Pandemic","volume":"34","author":"Ferrara","year":"2020","journal-title":"Eye"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/5\/952\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:30:06Z","timestamp":1760124606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/5\/952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["vaccines11050952"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11050952","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}